Avidity Partners Management LP
- SEC CIK
- 0001791827
- 最新申報
- 2026/8/14
2025 年第 1 季持倉
持倉截至 2025/3/31，2025/5/15 申報。只含多頭部位，變化是跟 2024 年第 4 季比股數。
- 持股檔數
- 63
- 較 2024 年第 4 季 +2
- 總值
- $4.85 億
- 較 2024 年第 4 季 −$5.18 億 (−51.7%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| BSXBoston Scientific Corp | Stock | 336,000 | $3,390 萬 | 7.0% | −179,000−34.8% | 減碼 | 歷史 |
| DNTHDianthus Therapeutics, Inc. | COM | 1,720,902 | $3,122 萬 | 6.4% | −1,152,098−40.1% | 減碼 | 歷史 |
| UNHUnitedHealth Group Inc | Stock | 50,500 | $2,645 萬 | 5.5% | −9,500−15.8% | 減碼 | 歷史 |
| CGONCG Oncology, Inc. | COM | 980,942 | $2,402 萬 | 5.0% | −116,858−10.6% | 減碼 | 歷史 |
| HUMHumana Inc | Stock | 81,000 | $2,143 萬 | 4.4% | −8,200−9.2% | 減碼 | 歷史 |
| NTRANatera, Inc. | COM | 119,200 | $1,686 萬 | 3.5% | −104,600−46.7% | 減碼 | 歷史 |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 25,400 | $1,611 萬 | 3.3% | +17,000+202.4% | 加碼 | 歷史 |
| EXASExact Sciences Corp | COM | 353,000 | $1,528 萬 | 3.2% | −250,011−41.5% | 減碼 | 歷史 |
| BEAMBeam Therapeutics Inc. | COM | 709,517 | $1,386 萬 | 2.9% | +709,517 | 新進 | 歷史 |
| GKOSGLAUKOS Corp | COM | 134,000 | $1,319 萬 | 2.7% | −36,000−21.2% | 減碼 | 歷史 |
| DXCMDexcom Inc | COM | 180,000 | $1,229 萬 | 2.5% | −138,000−43.4% | 減碼 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 322,100 | $1,166 萬 | 2.4% | −29,900−8.5% | 減碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 925,000 | $1,136 萬 | 2.3% | −575,000−38.3% | 減碼 | 歷史 |
| CORCencora, Inc. | Stock | 39,300 | $1,093 萬 | 2.3% | +39,300 | 新進 | 歷史 |
| JAZZJazz Pharmaceuticals plc | SHS USD | 80,000 | $993.2 萬 | 2.0% | −154,500−65.9% | 減碼 | 歷史 |
| THCTenet Healthcare Corp | COM NEW | 72,000 | $968.4 萬 | 2.0% | −65,000−47.4% | 減碼 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 85,700 | $947.8 萬 | 2.0% | −134,700−61.1% | 減碼 | 歷史 |
| DHRDanaher Corp | Stock | 44,500 | $912.3 萬 | 1.9% | −22,500−33.6% | 減碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 77,000 | $898.1 萬 | 1.9% | −111,000−59.0% | 減碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 107,000 | $816.3 萬 | 1.7% | −125,800−54.0% | 減碼 | 歷史 |
| OGNOrganon & Co. | Stock | 535,000 | $796.6 萬 | 1.6% | +535,000 | 新進 | 歷史 |
| TMOThermo Fisher Scientific Inc. | Stock | 15,500 | $771.3 萬 | 1.6% | −29,100−65.2% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 229,000 | $768.3 萬 | 1.6% | −245,000−51.7% | 減碼 | 歷史 |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 94,000 | $762.3 萬 | 1.6% | +94,000 | 新進 | – |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 529,000 | $760.7 萬 | 1.6% | −636,800−54.6% | 減碼 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 213,000 | $753.2 萬 | 1.6% | −233,200−52.3% | 減碼 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 481,000 | $739.3 萬 | 1.5% | +481,000 | 新進 | 歷史 |
| AVTRAvantor, Inc. | COM | 453,000 | $734.3 萬 | 1.5% | −494,000−52.2% | 減碼 | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 445,000 | $728.9 萬 | 1.5% | −681,700−60.5% | 減碼 | 歷史 |
| DOCSDoximity, Inc. | CL A | 122,500 | $710.9 萬 | 1.5% | +122,500 | 新進 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 258,000 | $696.6 萬 | 1.4% | −483,900−65.2% | 減碼 | 歷史 |
| HQYHealthequity, Inc. | COM | 78,000 | $689.3 萬 | 1.4% | +78,000 | 新進 | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 68,500 | $606.3 萬 | 1.3% | −108,100−61.2% | 減碼 | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 16,800 | $517.9 萬 | 1.1% | +16,800 | 新進 | 歷史 |
| PHATPhathom Pharmaceuticals, Inc. | COM | 800,000 | $501.6 萬 | 1.0% | −590,100−42.5% | 減碼 | 歷史 |
| IMUXImmunic, Inc. | COM | 4,454,408 | $485.5 萬 | 1.0% | −3,511,992−44.1% | 減碼 | 歷史 |
| BRKRBruker Corp | COM | 115,000 | $480.0 萬 | 1.0% | +38,700+50.7% | 加碼 | 歷史 |
| CATXPerspective Therapeutics, Inc. | COM NEW | 2,197,270 | $468.0 萬 | 1.0% | −497,330−18.5% | 減碼 | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 7,477,200 | $457.6 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 352,124 | $361.3 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| QUREuniQure N.V. | SHS | 336,200 | $356.4 萬 | 0.7% | +114,200+51.4% | 加碼 | 歷史 |
| BHVNBiohaven Ltd. | COM | 145,000 | $348.6 萬 | 0.7% | −77,900−34.9% | 減碼 | 歷史 |
| ARVNArvinas, Inc. | COM | 413,162 | $290.0 萬 | 0.6% | −944,838−69.6% | 減碼 | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 169,000 | $280.7 萬 | 0.6% | +169,000 | 新進 | 歷史 |
| RPRXRoyalty Pharma plc | SHS CLASS A | 87,000 | $270.8 萬 | 0.6% | +87,000 | 新進 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 75,000 | $259.3 萬 | 0.5% | +75,000 | 新進 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 502,600 | $245.3 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 57,000 | $230.7 萬 | 0.5% | −25,000−30.5% | 減碼 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 32,000 | $228.6 萬 | 0.5% | +32,000 | 新進 | 歷史 |
| CAPRCapricor Therapeutics, Inc. | COM NEW | 239,000 | $226.8 萬 | 0.5% | +239,000 | 新進 | 歷史 |
| LXEOLexeo Therapeutics, Inc. | COM | 645,000 | $223.8 萬 | 0.5% | +645,000 | 新進 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 91,000 | $218.6 萬 | 0.5% | −9,000−9.0% | 減碼 | 歷史 |
| RGNXREGENXBIO Inc. | COM | 260,000 | $185.9 萬 | 0.4% | −272,000−51.1% | 減碼 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 60,000 | $181.0 萬 | 0.4% | +60,000 | 新進 | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 40,000 | $180.2 萬 | 0.4% | −626,200−94.0% | 減碼 | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 68,000 | $139.2 萬 | 0.3% | −286,000−80.8% | 減碼 | 歷史 |
| AGLagilon health, inc. | COM | 305,100 | $132.1 萬 | 0.3% | +305,100 | 新進 | 歷史 |
| SCYXScynexis Inc | COM NEW | 1,228,910 | $117.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 23,000 | $86.8 萬 | 0.2% | +23,000 | 新進 | 歷史 |
| KPTIKaryopharm Therapeutics Inc. | COM NEW | 134,566 | $50.3 萬 | 0.1% | 00.0% | 不變依 1 比 15 拆股換算 | 歷史 |
| ELVNEnliven Therapeutics, Inc. | COM | 11,300 | $22.2 萬 | <0.1% | +11,300 | 新進 | 歷史 |
| HYPRHyperfine, Inc. | COM CL A | 222,174 | $15.9 萬 | <0.1% | −966,004−81.3% | 減碼 | 歷史 |
| RVPHReviva Pharmaceuticals Holdings, Inc. | COM | 138,000 | $13.2 萬 | <0.1% | +138,000 | 新進 | 歷史 |
選擇權（4 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2024 年第 4 季之後清倉（17 檔）
2024 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 4 季股數 | 2024 年第 4 季市值 | 2024 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| ISRGIntuitive Surgical Inc | COM NEW | 64,800 | $3,382 萬 | 3.4% | 歷史 |
| ACHCAcadia Healthcare Company, Inc. | COM | 658,000 | $2,609 萬 | 2.6% | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 500,000 | $2,012 萬 | 2.0% | 歷史 |
| ILMNIllumina, Inc. | COM | 109,700 | $1,466 萬 | 1.5% | 歷史 |
| ABBVAbbVie Inc. | Stock | 80,700 | $1,434 萬 | 1.4% | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,053,300 | $1,324 萬 | 1.3% | 歷史 |
| BMYBristol Myers Squibb Co | Stock | 215,000 | $1,216 萬 | 1.2% | 歷史 |
| TMDXTransMedics Group, Inc. | COM | 192,400 | $1,200 萬 | 1.2% | 歷史 |
| SGRYSurgery Partners, Inc. | Stock | 514,200 | $1,089 萬 | 1.1% | 歷史 |
| ORICOric Pharmaceuticals, Inc. | COM | 1,265,200 | $1,021 萬 | 1.0% | 歷史 |
| INCYIncyte Corp | COM | 129,600 | $895.1 萬 | 0.9% | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 62,000 | $853.6 萬 | 0.9% | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 97,000 | $810.1 萬 | 0.8% | 歷史 |
| KROSKeros Therapeutics, Inc. | COM | 210,000 | $332.4 萬 | 0.3% | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 96,000 | $226.2 萬 | 0.2% | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 287,104 | $223.9 萬 | 0.2% | 歷史 |
| BLUEbluebird bio, Inc. | COM NEW | 81,555 | $68.0 萬 | 0.1% | 歷史 |